Highlights

array(40) {
  [0]=>
  string(4) "8974"
  ["article_id"]=>
  string(4) "8974"
  [1]=>
  string(55) "Marken: COVID-19 shaking up clinical trial supply chain"
  ["article_title"]=>
  string(55) "Marken: COVID-19 shaking up clinical trial supply chain"
  [2]=>
  string(150) "With the pandemic causing unprecedented global interruptions to the clinical trial supply chain, the logistics company says bold solutions are needed."
  ["short_description"]=>
  string(150) "With the pandemic causing unprecedented global interruptions to the clinical trial supply chain, the logistics company says bold solutions are needed."
  [3]=>
  string(150) "With the pandemic causing unprecedented global interruptions to the clinical trial supply chain, the logistics company says bold solutions are needed."
  ["description"]=>
  string(150) "With the pandemic causing unprecedented global interruptions to the clinical trial supply chain, the logistics company says bold solutions are needed."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(151) "https://www.outsourcing-pharma.com/Article/2020/04/02/COVID-19-disrupts-clinical-trial-supply-chain?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(151) "https://www.outsourcing-pharma.com/Article/2020/04/02/COVID-19-disrupts-clinical-trial-supply-chain?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2030-04-02 23:25:00"
  ["add_date"]=>
  string(19) "2030-04-02 23:25:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Marken: COVID-19 shaking up clinical trial supply chain

With the pandemic causing unprecedented global interruptions to the clinical trial supply chain, the logistics company s

array(40) {
  [0]=>
  string(4) "9133"
  ["article_id"]=>
  string(4) "9133"
  [1]=>
  string(67) "First Wave BioPharma to Present at the DealFlow MicroCap Conference"
  ["article_title"]=>
  string(67) "First Wave BioPharma to Present at the DealFlow MicroCap Conference"
  [2]=>
  string(166) "BOCA RATON, Fla., Jan.  23, 2024  (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a"
  ["short_description"]=>
  string(166) "BOCA RATON, Fla., Jan.  23, 2024  (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a"
  [3]=>
  string(558) "

BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it will present at the DealFlow MicroCap Conference, which will be held January 30 – February 1, 2024 at the Caesars Atlantic City Hotel & Casino, in Atlantic City, New Jersey.

" ["description"]=> string(558) "

BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it will present at the DealFlow MicroCap Conference, which will be held January 30 – February 1, 2024 at the Caesars Atlantic City Hotel & Casino, in Atlantic City, New Jersey.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "25" ["rss_id"]=> string(2) "25" [14]=> string(139) "https://www.globenewswire.com/news-release/2024/01/23/2813928/0/en/First-Wave-BioPharma-to-Present-at-the-DealFlow-MicroCap-Conference.html" ["blog_url"]=> string(139) "https://www.globenewswire.com/news-release/2024/01/23/2813928/0/en/First-Wave-BioPharma-to-Present-at-the-DealFlow-MicroCap-Conference.html" [15]=> string(19) "2024-01-23 20:00:00" ["add_date"]=> string(19) "2024-01-23 20:00:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2024-01-23 20:20:28" ["create_at"]=> string(19) "2024-01-23 20:20:28" [19]=> string(0) "" ["slug"]=> string(0) "" }

First Wave BioPharma to Present at the DealFlow MicroCap Conference

BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FW

array(40) {
  [0]=>
  string(4) "9134"
  ["article_id"]=>
  string(4) "9134"
  [1]=>
  string(88) "ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP"
  ["article_title"]=>
  string(88) "ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP"
  [2]=>
  string(150) "BAUDETTE, Minn., Jan.  23, 2024  (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pento"
  ["short_description"]=>
  string(150) "BAUDETTE, Minn., Jan.  23, 2024  (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pento"
  [3]=>
  string(236) "

BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pentoxifylline Extended-Release (ER) Tablets, USP 400mg.

" ["description"]=> string(236) "

BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pentoxifylline Extended-Release (ER) Tablets, USP 400mg.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "25" ["rss_id"]=> string(2) "25" [14]=> string(159) "https://www.globenewswire.com/news-release/2024/01/23/2813922/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Pentoxifylline-Extended-Release-Tablets-USP.html" ["blog_url"]=> string(159) "https://www.globenewswire.com/news-release/2024/01/23/2813922/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Pentoxifylline-Extended-Release-Tablets-USP.html" [15]=> string(19) "2024-01-23 19:50:00" ["add_date"]=> string(19) "2024-01-23 19:50:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2024-01-23 20:20:28" ["create_at"]=> string(19) "2024-01-23 20:20:28" [19]=> string(0) "" ["slug"]=> string(0) "" }

ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP

BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Co

array(40) {
  [0]=>
  string(4) "9200"
  ["article_id"]=>
  string(4) "9200"
  [1]=>
  string(81) "Pharma manufacturer Gerresheimer gives Georgia an $88 million injection of funds "
  ["article_title"]=>
  string(81) "Pharma manufacturer Gerresheimer gives Georgia an $88 million injection of funds "
  [2]=>
  string(150) "Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, G"
  ["short_description"]=>
  string(150) "Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, G"
  [3]=>
  string(157) "Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, Georgia."
  ["description"]=>
  string(157) "Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, Georgia."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(165) "https://www.outsourcing-pharma.com/Article/2024/01/23/gerresheimer-medical-device-manufacturer-expands-in-georgia?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(165) "https://www.outsourcing-pharma.com/Article/2024/01/23/gerresheimer-medical-device-manufacturer-expands-in-georgia?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-23 19:41:00"
  ["add_date"]=>
  string(19) "2024-01-23 19:41:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Pharma manufacturer Gerresheimer gives Georgia an $88 million injection of funds

Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its o

array(40) {
  [0]=>
  string(4) "9179"
  ["article_id"]=>
  string(4) "9179"
  [1]=>
  string(78) "1MED unveils how to navigate 2024 MDR at Outsourcing in Clinical Trials Europe"
  ["article_title"]=>
  string(78) "1MED unveils how to navigate 2024 MDR at Outsourcing in Clinical Trials Europe"
  [2]=>
  string(156) "1MED, a Contract Research Organisation providing clinical and regulatory support to medical devices companies, is participating as a sponsor and ex"
  ["short_description"]=>
  string(156) "1MED, a Contract Research Organisation providing clinical and regulatory support to medical devices companies, is participating as a sponsor and ex"
  [3]=>
  string(259) "1MED, a Contract Research Organisation providing clinical and regulatory support to medical devices companies, is participating as a sponsor and exhibitor at the 12th Annual Outsourcing in Clinical Trials: Medical Devices Europe Conference in Munich."
  ["description"]=>
  string(259) "1MED, a Contract Research Organisation providing clinical and regulatory support to medical devices companies, is participating as a sponsor and exhibitor at the 12th Annual Outsourcing in Clinical Trials: Medical Devices Europe Conference in Munich."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(142) "https://www.medicalplasticsnews.com/news/medical-plastics-regulatory-policy-news/1med-unveils-solutions-to-mavigate-2024-mdr-at-clinical-tria/"
  ["blog_url"]=>
  string(142) "https://www.medicalplasticsnews.com/news/medical-plastics-regulatory-policy-news/1med-unveils-solutions-to-mavigate-2024-mdr-at-clinical-tria/"
  [15]=>
  string(19) "2024-01-23 19:22:25"
  ["add_date"]=>
  string(19) "2024-01-23 19:22:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:41"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

1MED unveils how to navigate 2024 MDR at Outsourcing in Clinical Trials Europe

1MED, a Contract Research Organisation providing clinical and regulatory support to medical devices companies, is

array(40) {
  [0]=>
  string(4) "9172"
  ["article_id"]=>
  string(4) "9172"
  [1]=>
  string(74) "Running on empty: The hidden dangers of poor nutrition advice for athletes"
  ["article_title"]=>
  string(74) "Running on empty: The hidden dangers of poor nutrition advice for athletes"
  [2]=>
  string(143) "Experts warn of short-term performance impact and long-term health risks as new research reveals poor nutrition support for endurance athletes."
  ["short_description"]=>
  string(143) "Experts warn of short-term performance impact and long-term health risks as new research reveals poor nutrition support for endurance athletes."
  [3]=>
  string(143) "Experts warn of short-term performance impact and long-term health risks as new research reveals poor nutrition support for endurance athletes."
  ["description"]=>
  string(143) "Experts warn of short-term performance impact and long-term health risks as new research reveals poor nutrition support for endurance athletes."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(160) "https://www.nutraingredients.com/Article/2024/01/23/The-hidden-dangers-of-poor-nutrition-advice-for-athletes?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(160) "https://www.nutraingredients.com/Article/2024/01/23/The-hidden-dangers-of-poor-nutrition-advice-for-athletes?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-23 18:45:00"
  ["add_date"]=>
  string(19) "2024-01-23 18:45:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:37"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Running on empty: The hidden dangers of poor nutrition advice for athletes

Experts warn of short-term performance impact and long-term health risks as new research reveals poor nutrition support

array(40) {
  [0]=>
  string(4) "9171"
  ["article_id"]=>
  string(4) "9171"
  [1]=>
  string(105) "Probiotic Bulgarian yogurt ‘feasible’ to achieve good health and well-being on Mars missions"
  ["article_title"]=>
  string(105) "Probiotic Bulgarian yogurt ‘feasible’ to achieve good health and well-being on Mars missions"
  [2]=>
  string(156) "Freshly made Bulgarian yogurt can feasibly be incorporated into an astronaut's diet to boost gut health and overall wellness in support of humanityâs"
  ["short_description"]=>
  string(156) "Freshly made Bulgarian yogurt can feasibly be incorporated into an astronaut's diet to boost gut health and overall wellness in support of humanityâs"
  [3]=>
  string(202) "Freshly made Bulgarian yogurt can feasibly be incorporated into an astronaut's diet to boost gut health and overall wellness in support of humanityâs extraterrestrial ambitions, says a new study."
  ["description"]=>
  string(202) "Freshly made Bulgarian yogurt can feasibly be incorporated into an astronaut's diet to boost gut health and overall wellness in support of humanityâs extraterrestrial ambitions, says a new study."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(163) "https://www.nutraingredients.com/Article/2024/01/23/Fresh-probiotic-Bulgarian-yogurt-feasible-for-Mars-missions?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(163) "https://www.nutraingredients.com/Article/2024/01/23/Fresh-probiotic-Bulgarian-yogurt-feasible-for-Mars-missions?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-23 17:23:00"
  ["add_date"]=>
  string(19) "2024-01-23 17:23:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:37"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Probiotic Bulgarian yogurt ‘feasible’ to achieve good health and well-being o

Freshly made Bulgarian yogurt can feasibly be incorporated into an astronaut's diet to boost gut health and overall

array(40) {
  [0]=>
  string(4) "9135"
  ["article_id"]=>
  string(4) "9135"
  [1]=>
  string(122) "HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq"
  ["article_title"]=>
  string(122) "HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq"
  [2]=>
  string(122) "HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq"
  ["short_description"]=>
  string(122) "HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq"
  [3]=>
  string(186) "

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq

" ["description"]=> string(186) "

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "25" ["rss_id"]=> string(2) "25" [14]=> string(186) "https://www.globenewswire.com/news-release/2024/01/23/2813810/0/en/HEPHAISTOS-Pharma-secures-a-2-million-seed-round-with-xista-science-ventures-Foundation-Fournier-Majoie-and-Noshaq.html" ["blog_url"]=> string(186) "https://www.globenewswire.com/news-release/2024/01/23/2813810/0/en/HEPHAISTOS-Pharma-secures-a-2-million-seed-round-with-xista-science-ventures-Foundation-Fournier-Majoie-and-Noshaq.html" [15]=> string(19) "2024-01-23 17:20:00" ["add_date"]=> string(19) "2024-01-23 17:20:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2024-01-23 20:20:28" ["create_at"]=> string(19) "2024-01-23 20:20:28" [19]=> string(0) "" ["slug"]=> string(0) "" }

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Found

HEPHAISTOS-Pharma secures a €2 million seed round with xista sc

array(40) {
  [0]=>
  string(4) "9136"
  ["article_id"]=>
  string(4) "9136"
  [1]=>
  string(135) "HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq"
  ["article_title"]=>
  string(135) "HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq"
  [2]=>
  string(135) "HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq"
  ["short_description"]=>
  string(135) "HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq"
  [3]=>
  string(199) "

HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq

" ["description"]=> string(199) "

HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "25" ["rss_id"]=> string(2) "25" [14]=> string(201) "https://www.globenewswire.com/news-release/2024/01/23/2813810/0/fr/HEPHAISTOS-Pharma-s%C3%A9curise-un-tour-de-table-de-2-millions-avec-xista-science-ventures-la-Fondation-Fournier-Majoie-et-Noshaq.html" ["blog_url"]=> string(201) "https://www.globenewswire.com/news-release/2024/01/23/2813810/0/fr/HEPHAISTOS-Pharma-s%C3%A9curise-un-tour-de-table-de-2-millions-avec-xista-science-ventures-la-Fondation-Fournier-Majoie-et-Noshaq.html" [15]=> string(19) "2024-01-23 17:20:00" ["add_date"]=> string(19) "2024-01-23 17:20:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2024-01-23 20:20:28" ["create_at"]=> string(19) "2024-01-23 20:20:28" [19]=> string(0) "" ["slug"]=> string(0) "" }

HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ven

HEPHAISTOS-Pharma sécurise un tour de table de €2 millions a

array(40) {
  [0]=>
  string(4) "9137"
  ["article_id"]=>
  string(4) "9137"
  [1]=>
  string(108) "German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN"
  ["article_title"]=>
  string(108) "German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN"
  [2]=>
  string(108) "German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN"
  ["short_description"]=>
  string(108) "German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN"
  [3]=>
  string(108) "German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN"
  ["description"]=>
  string(108) "German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "25"
  ["rss_id"]=>
  string(2) "25"
  [14]=>
  string(178) "https://www.globenewswire.com/news-release/2024/01/23/2813771/0/en/German-Pain-Association-DGS-and-Pharmaceutical-Company-Avextra-Join-Forces-to-Launch-Their-New-Study-OCEAN.html"
  ["blog_url"]=>
  string(178) "https://www.globenewswire.com/news-release/2024/01/23/2813771/0/en/German-Pain-Association-DGS-and-Pharmaceutical-Company-Avextra-Join-Forces-to-Launch-Their-New-Study-OCEAN.html"
  [15]=>
  string(19) "2024-01-23 16:30:00"
  ["add_date"]=>
  string(19) "2024-01-23 16:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:28"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch The

German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN

array(40) {
  [0]=>
  string(4) "9217"
  ["article_id"]=>
  string(4) "9217"
  [1]=>
  string(67) "2024 Health IT trends in India: Expanded healthcare AI applications"
  ["article_title"]=>
  string(67) "2024 Health IT trends in India: Expanded healthcare AI applications"
  [2]=>
  string(150) "Aside from clinical decision and diagnosis support, AI technology is also anticipated to assist with personalised treatments, clinical trials, and sel"
  ["short_description"]=>
  string(150) "Aside from clinical decision and diagnosis support, AI technology is also anticipated to assist with personalised treatments, clinical trials, and sel"
  [3]=>
  string(210) "Aside from clinical decision and diagnosis support, AI technology is also anticipated to assist with personalised treatments, clinical trials, and self health management, says Augnito founder Rustom Lawyer.&#nl"
  ["description"]=>
  string(210) "Aside from clinical decision and diagnosis support, AI technology is also anticipated to assist with personalised treatments, clinical trials, and self health management, says Augnito founder Rustom Lawyer.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(106) "https://www.healthcareitnews.com/news/asia/2024-health-it-trends-india-expanded-healthcare-ai-applications"
  ["blog_url"]=>
  string(106) "https://www.healthcareitnews.com/news/asia/2024-health-it-trends-india-expanded-healthcare-ai-applications"
  [15]=>
  string(19) "2024-01-23 15:15:46"
  ["add_date"]=>
  string(19) "2024-01-23 15:15:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

2024 Health IT trends in India: Expanded healthcare AI applications

Aside from clinical decision and diagnosis support, AI technology is also anticipated to assist with personalised treatm

array(40) {
  [0]=>
  string(4) "9138"
  ["article_id"]=>
  string(4) "9138"
  [1]=>
  string(26) "Ex dividend NOK 0.75 today"
  ["article_title"]=>
  string(26) "Ex dividend NOK 0.75 today"
  [2]=>
  string(100) "The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024."
  ["short_description"]=>
  string(100) "The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024."
  [3]=>
  string(107) "

The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.

" ["description"]=> string(107) "

The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "25" ["rss_id"]=> string(2) "25" [14]=> string(98) "https://www.globenewswire.com/news-release/2024/01/23/2813708/0/en/Ex-dividend-NOK-0-75-today.html" ["blog_url"]=> string(98) "https://www.globenewswire.com/news-release/2024/01/23/2813708/0/en/Ex-dividend-NOK-0-75-today.html" [15]=> string(19) "2024-01-23 15:00:00" ["add_date"]=> string(19) "2024-01-23 15:00:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2024-01-23 20:20:28" ["create_at"]=> string(19) "2024-01-23 20:20:28" [19]=> string(0) "" ["slug"]=> string(0) "" }

Ex dividend NOK 0.75 today

The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.